Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
about
Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive reviewExtending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization)Role of Transcatheter Intra-arterial Therapies for Hepatocellular CarcinomaTransarterial therapy: an evolving treatment modality of hepatocellular carcinomaManagement of hepatocellular carcinoma with portal vein thrombosisYttrium-90 radioembolization of liver tumors: what do the images tell us?Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveCancer concepts and principles: primer for the interventional oncologist-part IIGuidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167.Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.Radioembolization and the Dynamic Role of (90)Y PET/CTMinimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Radiation safety issues in y-90 microsphere selective hepatic radioembolization therapy: possible radiation exposure from the patients.Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.Preparation and complex characterization of silica holmium sol-gel monoliths.Radioembolization of hepatic tumorsPilot study of angiogenic response to yttrium-90 radioembolization with resin microspheresSelective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation TherapyYttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver.Radioembolization of yttrium-90 microspheres for hepatic malignancy.Colorectal hepatic metastasis: Evolving therapies.Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy.Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experiencePharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion.Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio.Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneityRadioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.Transcatheter intraarterial therapies: rationale and overviewEvaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration.Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheresPET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor ResponseA review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.
P2860
Q26772299-2336ACA1-0E02-4525-A94A-03FBA59BDB77Q26796524-A9061704-15C2-4E72-B733-0B447E750398Q26851627-5550B360-DD32-4DAF-B594-465B91602564Q26866514-B9357BA5-F7DB-4979-82C4-3A8007E8D672Q26996578-F7380A52-80D6-47E1-9F6D-B3EF1C634E0EQ26997064-C27E6A22-CE70-465B-B320-D81E217D73A2Q26998661-FAEB2306-040D-4168-A731-CC05E3265032Q27010961-02055DCD-2BDB-4F66-B104-4AEC953066F3Q30151984-AC817E9C-7B5F-4C6B-BE9E-D38312ACDC5CQ30415022-7509EFF8-C0DE-4C0A-9E55-24FD1A00A6A9Q30457523-482F2239-5ACA-4EEE-82F0-836C83569F4CQ30468280-E5C89F86-862D-4E7D-BE8E-C5D79D78B1D1Q33704034-E930E044-DEB1-48D3-BCDD-24CAC1E2E9C8Q33704156-C0C810AB-F34D-4AD6-AE0D-6DC4D8DFFF2BQ33715683-233F7466-43F4-476F-A015-4C02988C792BQ33763477-6BA373C6-2E31-4526-A5D7-0435AD33C272Q33820777-7EE7C3A6-640B-49CF-860A-49EE36C6F5A7Q33867596-31F48211-CDAA-4640-9A7E-DF82E0F263DAQ34045215-1D645CA0-4A55-4C37-B832-44A274EB85FDQ34059726-C324D428-1019-466C-AFEC-B98ACC83D288Q34118056-28067C35-46B2-423F-9142-F624DDB430E7Q34563356-D62342B5-31A5-44A9-8FF8-2257EB19857DQ34563515-F3D8F0B3-5BA2-4EE3-B774-8802D7265EA5Q34663557-DD5E5F9A-7232-40E8-A639-C8570C4E1D8AQ34991390-03C72A96-4460-4D79-91AE-025732840C20Q35164855-4AA315C7-0417-4148-B956-2A021B490FCBQ35675390-3B72660D-C054-42E7-959F-479236C3BB5EQ35687650-E9C3347D-DCA4-4947-98F5-30195792DEBCQ35720473-3412ED98-FC9F-48C6-B45F-106E55010E5DQ35721266-15C99F3C-D2B6-4718-8F9A-6D0992B6D3D2Q35738820-F17F0C57-432B-4224-B3F2-0745A2DFBCF6Q35985132-51C8D560-FE30-40C8-90E6-FA76D835F95EQ36062588-D38C605B-8204-4B9F-BE43-19BEB8A85053Q36104314-DFB856DD-89E2-420D-A039-FF683AE6BE86Q36157591-E4441E59-56A2-4708-B139-65E8ACA062DFQ36352452-C2DAC8AD-8575-4283-90E5-0FEDE608C8B3Q36697911-A2D58DDC-BD9C-48DF-B548-B4B812593B91Q36874720-21B81120-63D0-4F9E-8A9D-A5650A1ADE33Q36899620-BEE1A5A3-9B30-46E7-8461-1CF220997A87Q37068157-5A1DCEF9-6D10-4065-9842-7132D661200A
P2860
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathologic response and microd ...... f four explanted whole livers.
@ast
Pathologic response and microd ...... f four explanted whole livers.
@en
type
label
Pathologic response and microd ...... f four explanted whole livers.
@ast
Pathologic response and microd ...... f four explanted whole livers.
@en
prefLabel
Pathologic response and microd ...... f four explanted whole livers.
@ast
Pathologic response and microd ...... f four explanted whole livers.
@en
P2093
P1476
Pathologic response and microd ...... f four explanted whole livers.
@en
P2093
Andrew S Kennedy
Charles Nutting
Cinthia Drachenberg
Douglas Coldwell
James Gaiser
P304
P356
10.1016/J.IJROBP.2004.09.004
P407
P577
2004-12-01T00:00:00Z